Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synovial sarcoma of children and adolescents: the prognostic role of axial sites.
Ferrari A, Bisogno G, Alaggio R, Cecchetto G, Collini P, Rosolen A, Meazza C, Indolfi P, Garaventa A, De Sio L, D'Angelo P, Tamaro P, Casanova M, Carli M. Ferrari A, et al. Among authors: de sio l. Eur J Cancer. 2008 Jun;44(9):1202-9. doi: 10.1016/j.ejca.2008.03.016. Epub 2008 Apr 25. Eur J Cancer. 2008. PMID: 18440800
Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma.
Bisogno G, Ferrari A, Prete A, Messina C, Basso E, Cecchetto G, Indolfi P, Scarzello G, D'Angelo P, De Sio L, Di Cataldo A, Carli M. Bisogno G, et al. Among authors: de sio l. Eur J Cancer. 2009 Nov;45(17):3035-41. doi: 10.1016/j.ejca.2009.08.019. Epub 2009 Sep 25. Eur J Cancer. 2009. PMID: 19783136 Clinical Trial.
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).
Ciarapica R, De Salvo M, Carcarino E, Bracaglia G, Adesso L, Leoncini PP, Dall'Agnese A, Walters ZS, Verginelli F, De Sio L, Boldrini R, Inserra A, Bisogno G, Rosolen A, Alaggio R, Ferrari A, Collini P, Locatelli M, Stifani S, Screpanti I, Rutella S, Yu Q, Marquez VE, Shipley J, Valente S, Mai A, Miele L, Puri PL, Locatelli F, Palacios D, Rota R. Ciarapica R, et al. Among authors: de salvo m, de sio l. Oncogene. 2014 Aug 7;33(32):4173-84. doi: 10.1038/onc.2013.471. Epub 2013 Nov 11. Oncogene. 2014. PMID: 24213577
Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group.
Donfrancesco A, De Bernardi B, Carli M, Mancini A, Nigro M, De Sio L, Casale F, Bagnulo S, Helson L, Deb G. Donfrancesco A, et al. Among authors: de bernardi b, de sio l. Eur J Cancer. 1995;31A(4):612-5. doi: 10.1016/0959-8049(95)00068-t. Eur J Cancer. 1995. PMID: 7576980 Clinical Trial.
Temozolomide in resistant or relapsed pediatric solid tumors.
De Sio L, Milano GM, Castellano A, Jenkner A, Fidani P, Dominici C, Donfrancesco A. De Sio L, et al. Pediatr Blood Cancer. 2006 Jul;47(1):30-6. doi: 10.1002/pbc.20516. Pediatr Blood Cancer. 2006. PMID: 16047361 Clinical Trial.
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R, Milano GM, Garrè ML, Donfrancesco A. Fidani P, et al. Among authors: de ioris ma, de sio l. J Neurooncol. 2009 Apr;92(2):177-83. doi: 10.1007/s11060-008-9750-y. Epub 2008 Nov 29. J Neurooncol. 2009. PMID: 19048188 Clinical Trial.
99 results